Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Compound Astragalus Jianpi Oral Liquid is a traditional Chinese medicine (TCM) manufactured by Lanzhou Foci. It is an oral liquid formulation designed to treat syndromes characterized by spleen and qi deficiency. The preparation is a multi-herb 'compound' (Fufang) formula, with *Astragalus membranaceus* (Huangqi) as a primary active component. In the context of TCM, it is used to tonify the 'Qi', strengthen the digestive functions of the spleen, and improve overall vitality. Clinical indications typically include poor appetite, physical fatigue, and loose stools associated with weakened gastrointestinal health. As a TCM product, its therapeutic effects are attributed to the synergistic action of multiple botanical constituents rather than a single molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Compound Astragalus Jianpi Oral Liquid.